Braidwell »

Jatt Ii Acquisition Corp shares owned by Braidwell

Quarter-by-quarter ownership of Jatt Ii Acquisition Corp shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Jatt Ii Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Jatt Ii Acquisition Corp held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jatt Ii Acquisition Corp by Braidwell

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.8M 250k 11.36

More positions owned by Braidwell

Caris Life Sciences (CAI)
Hinge Health Cl A (HNGE)
Glaukos (GKOS)
Edgewise Therapeutics (EWTX)
Spyre Therapeutics Com New (SYRE)
Irhythm Technologies (IRTC)
Neogenomics Com New (NEO)
Kodiak Sciences (KOD)
Xenon Pharmaceuticals (XENE)
Alphatec Hldgs Note 0.750% 3/1 (Principal)
Monte Rosa Therapeutics (GLUE)
Dianthus Therapeutics (DNTH)
Neurocrine Biosciences (NBIX)
Alphatec Hldgs Com New (ATEC)
Generate Biomedicines Com Shs (GENB)

View all positions for Braidwell

Top funds holding Jatt Ii Acquisition Corp

Dr. Jeffrey R. Jay, M.D.
Jupiter Topco
Balyasny Asset Management
RA Capital Management
ADAR1 Capital Management
Franklin Resources
Atika Capital Management
Citadel Advisors
Farallon Capital Management
Braidwell
Nantahala Capital Management
Affinity Asset Advisors
TCG Crossover Management
Spruce Street Capital
Millennium Management

View all funds holding Jatt Ii Acquisition Corp